CONANT OPTICAL (02276) saw its shares increase by more than 3%. At the time of writing, the stock was up 3.64%, trading at HK$47.88, with a turnover of HK$21.072 million. Morgan Stanley released a research report noting that while revenue was slightly below expectations, leading to a recent significant pullback in the company's share price, the firm maintains a positive outlook on CONANT OPTICAL's XR business prospects. The company is set to complete and begin operations on a new "Neo Vision XR" production line in the second half of 2025, which is expected to start contributing significantly to revenue and profit in 2026. Additionally, CONANT OPTICAL continues to collaborate with approximately 20 smart glasses developers domestically and internationally. Mass production, anticipated to commence this year, is viewed as a major milestone for the company's XR business. Furthermore, the recent share price correction has made the valuation more reasonable. Morgan Stanley advises investors to consider accumulating shares gradually following the price pressure.
Comments